Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA – Get Rating) in a research note published on Monday morning. The brokerage issued a sell rating on the basic materials company’s stock.

Arcadia Biosciences Stock Up 2.0 %

NASDAQ RKDA opened at $8.21 on Monday. The firm has a market cap of $5.09 million, a price-to-earnings ratio of -0.23 and a beta of 0.13. The business has a 50-day moving average price of $1.61 and a 200-day moving average price of $0.87. Arcadia Biosciences has a twelve month low of $7.30 and a twelve month high of $106.40.

Hedge Funds Weigh In On Arcadia Biosciences

A number of hedge funds have recently made changes to their positions in RKDA. Armistice Capital LLC bought a new position in Arcadia Biosciences during the third quarter valued at approximately $850,000. State Street Corp boosted its stake in Arcadia Biosciences by 76.7% during the first quarter. State Street Corp now owns 99,300 shares of the basic materials company’s stock valued at $139,000 after buying an additional 43,100 shares during the last quarter. Renaissance Technologies LLC boosted its stake in Arcadia Biosciences by 66.5% during the second quarter. Renaissance Technologies LLC now owns 129,500 shares of the basic materials company’s stock valued at $130,000 after buying an additional 51,700 shares during the last quarter. Susquehanna International Group LLP boosted its stake in Arcadia Biosciences by 85.1% during the fourth quarter. Susquehanna International Group LLP now owns 282,419 shares of the basic materials company’s stock valued at $77,000 after buying an additional 129,811 shares during the last quarter. Finally, Jane Street Group LLC boosted its stake in Arcadia Biosciences by 215.8% during the first quarter. Jane Street Group LLC now owns 36,458 shares of the basic materials company’s stock valued at $51,000 after buying an additional 24,913 shares during the last quarter. Institutional investors own 13.33% of the company’s stock.

Arcadia Biosciences Company Profile

(Get Rating)

Arcadia Biosciences, Inc is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care.